75 (PB-075) Poster Prediction of response to neoadjuvant chemotherapy in HER2 positive breast cancer by MammaTyper®

Overview of attention for article published in European Journal of Cancer (1965), March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 6,907)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 21 news stories from 21 outlets.

Studies demonstrate superior performance and clinical benefits of MammaTyper® in HER2 testing These studies demonstrate the…

Studies demonstrate superior performance and clinical benefits of MammaTyper® in HER2 testing These studies demonstrate the…

Studies demonstrate superior performance and clinical benefits of MammaTyper® in HER2 testing These studies demonstrate the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 17 additional news stories.